This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (12)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Alzheimer Disease  • Neurogenetics  • Alert me on articles by topic

Alberto Lleó, MD,PhD; Rafael Blesa, MD,PhD; Rosa Queralt, PhD; Mario Ezquerra, PhD; José L. Molinuevo, MD,PhD; Jordi Peña-Casanova, MD,PhD; Ana Rojo, MD; Rafael Oliva, MD,PhD

Arch Neurol. 2002;59:1759-1763.

Background  The relative contribution of mutations in the presenilin (PSEN) and amyloid precursor protein genes to autosomal dominant and other early-onset Alzheimer disease (AD) cases is not well established.

Objectives  To clarify the respective contribution of the amyloid precursor protein and PSEN mutations to autosomal dominant AD and to determine its contribution to sporadic and familial nonautosomal dominant early-onset AD and familial late-onset AD in a referral-based Spanish population.

Subjects and Methods  Ninety-four patients with AD (60 with early-onset AD and 34 with late-onset AD) from 82 independent families were studied. According to the family history, patients were classified into the following groups: autosomal dominant, familial nonautosomal dominant, and sporadic. Mutational analysis of the coding regions of the amyloid precursor protein, presenilin 1, and presenilin 2 was performed in all patients. Apolipoprotein E was also genotyped.

Results  Of the 60 early-onset cases, 44 from 36 families had a positive family history (11 with autosomal dominant AD and 25 with familial nonautosomal dominant AD) and 16 were sporadic. The frequency of mutations was 54.6% (6/11) among the autosomal dominant group, 6.2% (1/16) among the sporadic group, and 4% (1/25) among the familial nonautosomal dominant AD group. Most PSEN mutations (92%) would have been detected using a cutoff age of 58 years. The apolipoprotein E 4 allele frequency was increased among early-onset AD without PSEN mutations.

Conclusions  More than half of the families with autosomal dominant early-onset AD can be explained by coding mutations in the PSEN genes. In the familial and sporadic early-onset groups mutations are rare. When family history is unavailable, an age of 58 years may be used as a cutoff point for genetic analysis. The increased apolipoprotein E 4 allele in patients without PSEN mutations confirms that it is an important risk factor in the cause of non-PSEN early-onset AD.

From the Neurology Service (Drs Lleó, Blesa, and Molinuevo) and Genetics Service (Drs Queralt, Ezquerra, and Oliva), Hospital Clínic Institut d' Investigacions Biomediques Agusti Pi i Sunyer, Neurology Service (Dr Peña-Casanova), Hospital del Mar Institut Municipal d'Assistencia Sanitaria, and Neurology Service, Hospital Mútua de Terrassa (Dr Rojo), Barcelona, Spain.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A novel PSEN2 mutation associated with a peculiar phenotype
Piscopo et al.
Neurology 2008;70:1549-1554.
ABSTRACT | FULL TEXT  

Novel Presenilin 1 Mutation (S170F) Causing Alzheimer Disease With Lewy Bodies in the Third Decade of Life
Snider et al.
Arch Neurol 2005;62:1821-1830.
ABSTRACT | FULL TEXT  

Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update
Raux et al.
J. Med. Genet. 2005;42:793-795.
ABSTRACT | FULL TEXT  

Emotional reactions to predictive testing in Alzheimer's disease and other inherited dementias
Molinuevo et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2005;20:233-238.
ABSTRACT  

Clinical, Pathological, and Biochemical Spectrum of Alzheimer Disease Associated With PS-1 Mutations
Lleo et al.
AJGP 2004;12:146-156.
ABSTRACT | FULL TEXT